Biodexa Pharmaceuticals (BDRX) Interest Income - Total (2019 - 2020)
Biodexa Pharmaceuticals (BDRX) reported Interest Income - Total of -$670789.1 for Q4 2020, down 52072.06% on a YoY basis from N/an in Q1 2020, and down 4.86% sequentially from -$639714.4 in Q3 2020.
Biodexa Pharmaceuticals (BDRX) Interest Income - Total (2019 - 2020) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 2 years of Interest Income - Total data on file, last reported at -$670789.1 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -230,118.75 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -670,789.11 |
| Dec 31, 2020 | -670,789.11 |
| Sep 10, 2020 | -639,714.43 |
| Sep 10, 2020 | -639,714.43 |
| Dec 31, 2019 | -1,285.72 |
| Dec 31, 2019 | -1,285.72 |